(Q44580567)

4 December 2017

title

Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists (English)

1 reference

4 December 2017

1 reference

Churg-Strauss syndrome

1 reference

Karina A Keogh

1

1 reference

4 December 2017

Ulrich Specks

series ordinal

2

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

American Journal of Medicine

4 December 2017

published in

1 reference

4 December 2017

volume

115

1 reference

4 December 2017

issue

4

1 reference

4 December 2017

page(s)

284-290

1 reference

Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome.

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

The American College of Rheumatology 1990 criteria for the classification of churg-strauss syndrome (allergic granulomatosis and angiitis)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Churg-Strauss syndrome associated with zafirlukast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Zafirlukast and Churg-Strauss syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Pulmonary eosinophilia associated with montelukast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Churg-Strauss syndrome associated with montelukast therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Churg-Strauss Syndrome in Patients Receiving Montelukast as Treatment for Asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Churg-Strauss syndrome after reduction of inhaled corticosteroid in a patient treated with pranlukast for asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Leukotriene antagonists and the Churg-Strauss syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Cutaneous manifestations of Churg-Strauss syndrome: a clinicopathologic correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Churg-Strauss syndrome complicated by eosinophilic endomyocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Anticytoplasmic autoantibodies in the diagnosis and follow-up of Wegener's granulomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Anti-neutrophil cytoplasmic antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Formes frustes of Churg-Strauss syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Churg-Strauss syndrome in a district hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Churg-Strauss syndrome: outcome and long-term follow-up of 32 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

The use and misuse of classification and diagnostic criteria for complex diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Wegener Granulomatosis: An Analysis of 158 Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Antineutrophil cytoplasmic antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Human mast cells expressing recombinant proteinase 3 (PR3) as substrate for clinical testing for anti-neutrophil cytoplasmic antibodies (ANCA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Detection of autoantibodies against myeloid lysosomal enzymes: A useful adjunct to classification of patients with biopsy-proven necrotizing arteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

7 January 2021

Churg-Strauss syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Eosinophilia in Wegener's granulomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Anti-myeloperoxidase antibodies in Churg-Strauss syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Characterization of the human cysteinyl leukotriene CysLT1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Immunologic components of hypersensitivity reactions to cromolyn sodium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Inhaled corticosteroids and Churg-Strauss syndrome: a report of five cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

Leukotriene antagonists: bystanders or causes of Churg-Strauss syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900359-0

10.1016/S0002-9343(03)00359-0

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference